Prevalence, risk factors, quality of life, and awareness of MASLD among Egyptian university students: a cross-sectional study by Mohamed El-Kassas, Marwa Romeih, Abobakrelsedik Fangary, Ali Abouelyazeed, Islam Abdelfattah, Aya Alerian, Ahmed Ekbal, Yosra Abdelsalam Elshaikh, Samar Abbas, Marwa Tahoon, Hanaa Nagdy, Mohamed Elbadry

Subjects: Get full text

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes by Ankita Dua, Rashmi Kumari, Mona Singh, Roushan Kumar, Sunila Pradeep, Sunila Pradeep, Akinyemi I. Ojesina, Akinyemi I. Ojesina, Akinyemi I. Ojesina, Roshan Kumar, Roshan Kumar, Roshan Kumar

Subjects: “…MASLD…”
Get full text

Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom by Elizabeta Knezović, Marija Hefer, Suzana Blažanović, Ana Petrović, Vice Tomičić, Nika Srb, Damir Kirner, Robert Smolić, Martina Smolić

Subjects: “…MASLD…”
Get full text

Glycemic variability in type 2 diabetic patients with metabolic dysfunction-associated steatotic liver disease: a case-control study by Yueqiu Wang, Jing Liu, Yaoqin Yang, Qiong Wang, Yiqiong Sun, Ruiting Shen, Mingchen Zhang

Subjects: Get full text

Therapeutic Potential of Ellagic Acid in Liver Diseases by Karolina Wojtunik-Kulesza, Przemysław Niziński, Anna Krajewska, Tomasz Oniszczuk, Maciej Combrzyński, Anna Oniszczuk

Subjects: Get full text

Hepatoprotective Effect of Kaempferol—A Review by Przemysław Niziński, Anna Krajewska, Tomasz Oniszczuk, Beata Polak, Anna Oniszczuk

Subjects: Get full text

Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease Model by Shunta Yakubo, Hiroyuki Abe, Yawen Li, Marina Kudo, Atsushi Kimura, Takuya Wakabayashi, Yusuke Watanabe, Naruhiro Kimura, Toru Setsu, Takeshi Yokoo, Akira Sakamaki, Hiroteru Kamimura, Atsunori Tsuchiya, Kenya Kamimura, Shuji Terai

Subjects: “…MASLD…”
Get full text

Association between estimated glucose disposal rate and metabolic dysfunction-associated steatotic liver disease and dyslipidemia in US adults: a cross-sectional study by Deliang Liu, Deliang Liu, Xiaojun Lv, Xiaojun Lv, Wenwen Li, Wenwen Li, Hongsheng Dai, Hongsheng Dai, Yang Tan, Yang Tan, Dandan Yang, Dandan Yang, Xiaoqian Zhang, Xiaoqian Zhang

Subjects: Get full text

Potential predictive role of Non-HDL to HDL Cholesterol Ratio (NHHR) in MASLD: focus on obese and type 2 diabetic populations by Xiao-Man Ma, Yu-Miao Guo, Shu-Yi Jiang, Ke-Xuan Li, Ya-Fang Zheng, Xu-Guang Guo, Zhi-Yao Ren

Subjects: “…MASLD…”
Get full text

Naringenin cationic lipid-modified nanoparticles mitigate MASLD progression by modulating lipid homeostasis and gut microbiota by Lu Dong, Wenyong Lou, Congfei Xu, Juan Wang

Subjects: Get full text

A Defective Circulating Mitochondrial Bioenergetics Profile Reflects the Hepatic One and Outlines Genetic MASLD by Erika Paolini, Miriam Longo, Marica Meroni, Paola Podini, Marco Maggioni, Angelo Quattrini, Anna Ludovica Fracanzani, Paola Dongiovanni

Subjects: “…MASLD…”
Get full text

Characterizing outcomes in a large cohort of latinx patients with autoimmune hepatitis by Eleanor Belilos, Jessica Strzepka, Ethan Ritz, Nancy Reau, Costica Aloman

Subjects: “…MASLD…”
Get full text

A narrative review about cognitive impairment in Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD): Another matter to face through a holistic approach by Marica Meroni, Miriam Longo, Erika Paolini, Paola Dongiovanni

Subjects: “…MASLD…”
Get full text

Milpa Diet for MASLD in Mesoamerican Populations: Feasibility, Advantages, and Future Perspectives by Aline Huerta-Álvarez, Mariana Arellano, Clyo Anahí Chávez-Méndez, Paulina Carpinteyro-Espin, Carmen Palacios-Reyes, Juanita Pérez-Escobar

Subjects: Get full text

Liver stiffness and serum galectin 3 level significantly increases in patients with prediabetes: a fibroscan study by Huseyin Ali Ozturk, Hilmi Erdem Sumbul

Subjects: Get full text

Diet, oxidative stress and MAFLD: a mini review by Zenan Hu, Zenan Hu, Hanxun Yue, Na Jiang, Liang Qiao

Subjects: Get full text

Outcomes of coronary revascularization in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review by Jacob J. Gries, Hafeez Ul Hassan Virk, Zhen Wang, Zhen Wang, Mahboob Alam, Samin Sharma, Markus Strauss, Markus Strauss, Chayakrit Krittanawong

Subjects: Get full text

Association of gut microbiota dietary index with metabolic dysfunction-associated steatotic liver disease: the mediating roles of inflammation and body mass index by Yu Pu, Zongbiao Tan, Yanrui Wu, Suqi Zeng, Haodong He, Jixiang Zhang, Weiguo Dong

Subjects: Get full text

Green tea epigallocatechin gallate attenuate metabolic dysfunction-associated steatotic liver disease by regulation of pyroptosis by Jie Zhang, Shuangshuang Wang, Ting Zhang, Minghui Zi, Shuxiang Wang, Qiao Zhang

Subjects: Get full text

Impact of Gut Microbiome on Gut Permeability in Liver and Gut Diseases by Punnag Saha, Phillipp Hartmann

Subjects: Get full text